Drug Profile
Monoclonal antibody NG-1
Alternative Names: Monopharm GLatest Information Update: 17 Nov 2010
Price :
$50
*
At a glance
- Originator Hygeia Pharmaceuticals
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Jul 1998 Profile reviewed
- 14 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 01 Feb 1995 Preclinical development for Cancer in USA (Unknown route)